Prognostic factors in patients with recurrent or metastatic retroperitoneal leiomyosarcoma.

AIMS Factors that predict the prognosis of patients with recurrent or metastatic retroperitoneal leiomyosarcomas after treatment are uncertain. MATERIALS & METHODS Clinical and pathological data on 22 patients with retroperitoneal leiomyosarcomas who were treated by a multidisciplinary abdominal soft-tissue tumor group were analyzed retrospectively to identify prognostic factors for their progression-free survival (PFS). RESULTS & CONCLUSION The median PFS in the 22 patients was 9 months. Microvessel density in tumor tissues, which was evaluated via CD34 expression in 16 cases, and the presence of metastasis on admission were both found to be correlated with PFS in a Kaplan-Meier analysis, but not in a multivariate analysis. The multivariate analysis did, however, show that complete resection of tumors and the FNCLCC (Fédération Nationale des Centres de Lutte Contre Le Cancer) disease grade were independent factors predicting PFS.

[1]  L. Mariani,et al.  Personalizing the Approach to Retroperitoneal Soft Tissue Sarcoma: Histology-specific Patterns of Failure and Postrelapse Outcome after Primary Extended Resection , 2015, Annals of Surgical Oncology.

[2]  J. Blay,et al.  Retroperitoneal sarcomas: patterns of care in advanced stages, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  Narasimhan P. Agaram,et al.  Predictors of Survival and Recurrence in Primary Leiomyosarcoma , 2013, Annals of Surgical Oncology.

[4]  P. Thongsuksai,et al.  Chalkley microvessel but not lymphatic vessel density correlates with axillary lymph node metastasis in primary breast cancers. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[5]  Saeid Amanpour,et al.  Correlation of microvessel density with nuclear pleomorphism, mitotic count and vascular invasion in breast and prostate cancers at preclinical and clinical levels. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[6]  A. Lazarev,et al.  Prognostic Value of Microvessel Density in Tumor and Peritumoral Area as Evaluated by CD31 Protein Expression and Argyrophilic Nucleolar Organizer Region Count in Endothelial Cells in Uterine Leiomyosarcoma , 2012, Sarcoma.

[7]  D. Zurakowski,et al.  Outcomes and prognostic factors for a consecutive case series of 115 patients with somatic leiomyosarcoma. , 2012, The Journal of bone and joint surgery. American volume.

[8]  Łukasz Szylberg,et al.  [Evaluation of microvessel density (MVD) in laryngeal squamous cell carcinoma]. , 2012, Przeglad lekarski.

[9]  Andrew H. Beck,et al.  CSF1 expression in nongynecological leiomyosarcoma is associated with increased tumor angiogenesis. , 2011, The American journal of pathology.

[10]  K. Moon,et al.  Localized Resectable Genitourinary Sarcoma in Adult Korean Patients: Experiences at a Single Center , 2011, Yonsei medical journal.

[11]  J. Cheville,et al.  Leiomyosarcoma of the urinary bladder: a clinicopathological study of 34 cases , 2010, Journal of Clinical Pathology.

[12]  M. Choti,et al.  Predictors of Survival After Resection of Retroperitoneal Sarcoma: A Population-Based Analysis and Critical Appraisal of the AJCC Staging System , 2009, Annals of surgery.

[13]  David M. Thomas,et al.  Current concepts and future perspectives in retroperitoneal soft-tissue sarcoma management , 2009, Expert review of anticancer therapy.

[14]  A. Sanchez,et al.  Retroperitoneal Soft Tissue Sarcoma: Prognostic Factors and Therapeutic Approaches , 2008, Tumori.

[15]  T. Nicol,et al.  Complete hepatic resection of metastases from leiohyosarcoma prolongs survival , 1998, Journal of Gastrointestinal Surgery.

[16]  L. Koniaris,et al.  Retroperitoneal and Truncal Sarcomas: Prognosis Depends Upon Type Not Location , 2007, Annals of Surgical Oncology.

[17]  P. Pisters,et al.  Retroperitoneal sarcoma , 2006, Cancer.

[18]  C. Pilarsky,et al.  Retroperitoneal soft tissue sarcomas: prognosis and treatment of primary and recurrent disease in 117 patients. , 2006, Anticancer research.

[19]  J. Coindre,et al.  Sarcomes des tissus mous : données anatomopathologiques actuelles , 2006 .

[20]  E. Darai,et al.  Prognostic value of von Willebrand factor, CD34, CD31, and vascular endothelial growth factor expression in women with uterine leiomyosarcomas , 2004, Journal of surgical oncology.

[21]  S. Singer,et al.  Evaluation of a Clinically Applicable Post-Surgical Classification System for Primary Retroperitoneal Soft-Tissue Sarcoma , 2004, Annals of Surgical Oncology.

[22]  S. Weiss.  Smooth Muscle Tumors of Soft Tissue , 2002, Advances in anatomic pathology.

[23]  N. Kinukawa,et al.  Clinicopathological prognostic factors in soft tissue leiomyosarcoma: a multivariate analysis , 2002, Histopathology.

[24]  F. Collin,et al.  Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas , 2001, Cancer.

[25]  M. Brennan,et al.  Management of soft tissue sarcoma , 1996, The British journal of surgery.

[26]  Mårten Fernö,et al.  Soft tissue leiomyosarcoma. A population‐based epidemiologic and prognostic study of 48 patients, including cellular dna content , 1992, Cancer.

[27]  J. Coindre,et al.  Soft‐tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system , 1984, International journal of cancer.

[28]  A. Wile,et al.  Leiomyosarcoma of soft tissue: A clinicopathologic study , 1981, Cancer.